40 unchanged sentences
for the foreseeable future.
−Removed: A number of factors, including, but not limited
−Removed: to the following, may affect our ability to develop our business and operate profitably:
−Removed: our ability to obtain necessary funding to develop our proposed products;
−Removed: the success of clinical trials for our products;
−Removed: our ability to obtain FDA approval for us to market any proposed product in our pipeline in the United States;
−Removed: any delays in regulatory review and approval of product in development;
−Removed: if we obtain FDA approval to market our product, our ability to establish manufacturing and distribution operations or entering into manufacturing and distribution agreements with qualified third parties;
−Removed: market acceptance of our products;
−Removed: our ability to establish an effective sales and marketing infrastructure;
−Removed: our ability to protect our intellectual property;
−Removed: competition from existing products or new products that may emerge;
−Removed: the ability to commercialize our products;
−Removed: potential product liability claims and adverse events;
−Removed: our ability to adequately support future growth;
−Removed: our ability to attract and retain key personnel to manage our business effectively.
Our business is impacted by the following additional
10 unchanged sentences
We may not be able to enter into such a relationship, and any relationship may not be successful, and the other party may have business interests and priorities that are different from ours.
−Removed: We are party to a settlement agreement with the SEC resulting from statements in our SEC filings that did not accurately reflect the FDA’s jurisdiction over our consumer products and did not disclose that we could not legally market these products in the United States.
−Removed: The settlement included a cease-and-desist order against violating the provisions of the Securities Exchange Act which require us to file accurate registration statements and annual reports with the SEC.
−Removed: Our failure to comply with our obligations under the settlement agreement could result in enforcement proceedings against us or our officers.
−Removed: We may not be able to protect our rights in our intellectual property, and we may be subject to intellectual property litigation which would be expensive and disruptive of our operations even if we eventually prevail on the merits.
−Removed: Unanticipated side effects or other adverse events resulting from the use of our product could require a recall of our products and, even if no recall is required, our reputation could be impaired by side effects.
−Removed: We may not be able to evaluate potential acquisition candidates, with the result that we may not be able to benefit from the acquisition or integrate the acquired business with our business.
−Removed: We have recently incurred an impairment charge as a result of an acquisition when the intellectual property assets of the acquired company were not as represented.
−Removed: We cannot assure you that we will not incur similar or other problems with any future acquisitions.
−Removed: We may fail to comply with all applicable laws and regulations relating to our product.
−Removed: We may have to change or adapt our operations in the event of changes in national, regional and local government regulations, taxation, controls and political and economic developments that affect our products and the market for our products;
We may be unable to accurately estimate anticipated expenses, capital requirements and needs for additional financing;
13 unchanged sentences
NUTRIBAND INC.
+Added: September 8, 2023
/s/ Gareth Sheridan
2 unchanged sentences
(Principal Executive Officer)
+Added: September 8, 2023
/s/ Gerald Goodman
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.